Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2025-12-27 @ 10:05 AM
Study NCT ID:
NCT00405392
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2006-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2008-05-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05-27
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-29
First Submit QC Date:
None
Study First Post Date:
2006-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-15
Results First Submit QC Date:
None
Results First Post Date:
2018-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-04
Last Update Post Date:
2018-06-06
Last Update Post Date Type:
ACTUAL